Last reviewed · How we verify

Bupivacaine HCl infiltration

Innocoll · Phase 3 active Small molecule

Bupivacaine HCl infiltration is a Local anesthetic Small molecule drug developed by Innocoll. It is currently in Phase 3 development for Local infiltration anesthesia for surgical procedures. Also known as: Marcaine, Marcaine; Local Infiltration.

Bupivacaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Bupivacaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. Used for Local infiltration anesthesia for surgical procedures.

At a glance

Generic nameBupivacaine HCl infiltration
Also known asMarcaine, Marcaine; Local Infiltration
SponsorInnocoll
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhasePhase 3

Mechanism of action

Bupivacaine reversibly binds to and blocks voltage-gated sodium channels on the inner surface of nerve cell membranes, preventing depolarization and action potential propagation. This results in local anesthesia and loss of sensation in the infiltrated tissue. The HCl salt form enhances solubility and stability for clinical administration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Bupivacaine HCl infiltration

What is Bupivacaine HCl infiltration?

Bupivacaine HCl infiltration is a Local anesthetic drug developed by Innocoll, indicated for Local infiltration anesthesia for surgical procedures.

How does Bupivacaine HCl infiltration work?

Bupivacaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

What is Bupivacaine HCl infiltration used for?

Bupivacaine HCl infiltration is indicated for Local infiltration anesthesia for surgical procedures.

Who makes Bupivacaine HCl infiltration?

Bupivacaine HCl infiltration is developed by Innocoll (see full Innocoll pipeline at /company/innocoll).

Is Bupivacaine HCl infiltration also known as anything else?

Bupivacaine HCl infiltration is also known as Marcaine, Marcaine; Local Infiltration.

What drug class is Bupivacaine HCl infiltration in?

Bupivacaine HCl infiltration belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Bupivacaine HCl infiltration in?

Bupivacaine HCl infiltration is in Phase 3.

What are the side effects of Bupivacaine HCl infiltration?

Common side effects of Bupivacaine HCl infiltration include Injection site reactions, Systemic toxicity (CNS effects), Cardiovascular effects, Allergic reactions.

What does Bupivacaine HCl infiltration target?

Bupivacaine HCl infiltration targets Voltage-gated sodium channels and is a Local anesthetic.

Related